Agree.net – Lifestyle
Author:
Vicore Pharma Holding
Vicore Pharma Completes Enrollment in the Phase 2b ASPIRE Trial of Buloxibutid in Idiopathic Pulmonary Fibrosis
April 22, 2026
Notice Of Annual General Meeting In Vicore Pharma Holding AB (PUBL)
April 1, 2026
Vicore Publishes the Annual Report for 2025
March 26, 2026
Vicore Pharma to Present at Upcoming Investor Conferences
March 9, 2026
Vicore Pharma Elevates Leadership Team Ahead of Key Clinical and Corporate Milestones
March 5, 2026